Funder: National Psoriasis Foundation
Due Dates: January 15, 2027, at 11:59 p.m. ET (Application) | June 30, 2027 (Anticipated notification)
Funding Amounts: Up to $100,000 per year for two years, October 1, 2027–September 30, 2029
Summary: Supports rapid translation of basic scientific discoveries into clinical applications with clear benefits for patients with psoriatic disease.
Key Information: Principal investigators must hold an M.D., Ph.D., or equivalent degree and have institutional eligibility to serve as PI.
Description
The National Psoriasis Foundation (NPF) Translational Research Grants support innovative research that rapidly advances basic scientific discoveries toward clinical applications benefiting people with psoriasis and psoriatic arthritis. Applications addressing all aspects of psoriatic disease are encouraged. The funded portfolio includes basic science, technology development, public health, and clinical research.
Review prioritizes a thoughtful account of the translational pathway needed to move proposed aims toward clinical reality. NPF emphasizes commitments to interinstitutional or interdisciplinary research and encourages applicants to consider published research gaps and priorities. Applicants may also draw on thematic priorities identified by clinical, research, and patient stakeholders in NPF’s FY25–29 Strategic Plan.
